3rd ESTRO Forum 2015 S845 useful to analyse stability and temporal trends of different image parameters.
Purpose/Objective:
In high precision radiotherapy, knowledge of the radiation source position is crucial. The radiation source should ideally be positioned at the rotational axis of the collimator at any gantry angle. In dose planning systems the radiation source is assumed to be on the collimator axis and at the same position relative to the collimator rotational axis at all gantry angles. The aim of this work is to evaluate the target spot position and stability of different linacs. Materials and Methods: A dedicated phantom was designed with two tungsten-carbide ball bearings at two different distances from the target spot. One positioned next to the beam exit window of the linac and the other far from it. Both ball bearings were placed off the collimator rotational axis. The phantom was firmly attached to the linac gantry head. Four different linacs were included in the study. The electronic portal imaging device (EPID) of the linacs were used to acquire MV images of the phantom at 12 collimator angles at 30 o intervals. A MATLAB code was developed to extract the position of the balls. Results: Results of the target spot position measurements at gantry 180 o for four different linacs are displayed in Table 1 . The target spot position was also investigated for both 6 and 18 MV beams. The parameters r and Φ refer to the calculated polar coordinates locating the target spot position relative to the rotational axis of the collimator. The SD values represent one standard deviation of the parameters. The standard deviations of r and Φ were found to be negligible. 
Materials and Methods:
A Quasar phantom with dynamic sphere (2cm diameter) and a cube (3cm side) was used to simulate organ motion in longitudinal direction (S-I). A 4DCT exam and a VisionRT® surface tracking systems have allowed to acquire a simulated breathing signal and reconstruct 4DCT images in 10 bin phases. The study was analyzed by Raystation® in which sphere and cube were initially contoured like ROI in phase 0% and mapped to the others phases. Using Hybrid DIR algorithm (deformation grid resolution cm/voxel: 0.1 R-L, 0.20 I-S, 0.1 P-A), the morphed ROIs were propagated in each single phases. The interval time of reconstruction between phases was 500 ms and the maximum length of motion for the inserts is 1.5cm during the full breathing cycle (0.15cm per Bin). Position and time of the objects motion is well defined in each instant, using a POI (Center of Mass) per each ROIs propagated. DIR algorithm with reverse ROI mapping, can allow to evaluate the motion object between the 4DCT exams and the DVF analysis.
Results: Figure 1a shows the cube propagation in the coronal direction and DVF of the inserts. Mean S-I distance are 0.16±0.14cm for cube and 0.27±0.12cm for sphere. DVF have a mean magnitude scale of 0.00-1.11cm for the 4DCT. The mean transition has same dimension, according to the space covered by the objects during phases bin. The motion direction is obtained by reverse mode, otherwise uncorrected track is provided by the DVF module. Graph (Figure1b) shows the displacement of 2 ROIs in S-I directions per phases. A strong correlation (R 2 =0.95) with position, time and direction of the inserts (cube and sphere) is obtained (Figure 1c) . Purpose/Objective: IMRT is an established treatment option for patients with prostate cancer, as it allows the delivery of highly conformal doses to the target whilst lowering doses to OARs. In many centres, including ours, the provision of static field IMRT has been supplanted by VMAT which offers faster treatment times and greater monitor unit efficiency. The results of published dosimetric comparisons between IMRT and VMAT for prostate cancer have varied, typically with small sample sizes. Here we present a retrospective dosimetric audit of clinical IMRT and VMAT treatment plans for prostate cancer with a large sample size (N = 1344). Materials and Methods: Our standard prostate treatment is a three dose level integrated simultaneous-boost technique based on the CHHiP trial, with a prescription dose of 60Gy in 20 fractions, delivery of which has moved from five-field step-and-shoot IMRT to predominantly single arc VMAT using Elekta linear accelerators. Planning is performed using the Philips Pinnacle TPS. Automatically populated dosimetric summary forms (AutoForms) are routinely generated at our centre for the purposes of optimisation and reporting. Prostate AutoForms were collected and cross-referenced with treatment planning system PDF reports to determine which patients were treated with IMRT or VMAT. Patients with artificial hip replacements were excluded as we do not treat these patients with VMAT. All data collection was fully automated. Target, rectum and bladder dosimetric statistics were compared using histograms and Mann-Whitney U tests, with a significance level of 0.01. It should be noted that our standard VMAT inverse optimisation class solution is slightly different to the IMRT version. However, all plans have been individually optimised by suitably trained individuals.
Conclusions
Results: The volume of rectum receiving 41% of the prescription dose or greater, V41%, and V88% were significantly lower for VMAT than IMRT. However, V68% and V95% were significantly higher. Bladder dose statistics (V68%, V81% and V100%) were lower for VMAT but the differences were not significant. The percentage of the prescription dose covering 99% of each target volume, D99%, was significantly higher for VMAT than for IMRT. Sharp cut-offs at tolerance values were much more pronounced in the histograms for IMRT than for VMAT, supporting anecdotal evidence that coverage tolerances are more easily achieved using VMAT. Heterogeneity, defined as the difference between the maximum and minimum percentage dose to 1cc of the target volume, was significantly lower for VMAT than IMRT. 
